BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 9803612)

  • 1. Prevalence of antibody to hepatitis D virus among HBsAg-positive drug-dependent patients in Jeddah, Saudi Arabia.
    Njoh J; Zimmo S
    East Afr Med J; 1998 Jun; 75(6):327-8. PubMed ID: 9803612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prevalence of hepatitis B surface antigen (HBsAg) among drug-dependent patients in Jeddah, Saudi Arabia.
    Njoh J
    East Afr Med J; 1995 Mar; 72(3):198-9. PubMed ID: 7796776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular epidemiological and clinical aspects of hepatitis D virus in a unique triple hepatitis viruses (B, C, D) endemic community in Taiwan.
    Lu SN; Chen TM; Lee CM; Wang JH; Tung HD; Wu JC
    J Med Virol; 2003 May; 70(1):74-80. PubMed ID: 12629646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High prevalence of dual or triple infection of hepatitis B, C, and delta viruses among patients with chronic liver disease in Mongolia.
    Tsatsralt-Od B; Takahashi M; Nishizawa T; Endo K; Inoue J; Okamoto H
    J Med Virol; 2005 Dec; 77(4):491-9. PubMed ID: 16254981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prevalence of HBV surface antigens, anti-HBD and anti-HCV antibodies in patients with virus-related chronic liver disease].
    Ozyilkan E; Tatar G; Köseoğlu T; Ozkuyumcu C; Kayhan B; Telatar H
    Mikrobiyol Bul; 1993 Oct; 27(4):308-13. PubMed ID: 7505386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of hepatitis B virus markers among drug-dependent patients in Jeddah Saudi Arabia.
    Njoh J
    East Afr Med J; 1995 Aug; 72(8):490-1. PubMed ID: 7588140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High prevalence of hepatitis B, C and delta virus infections among blood donors in Mongolia.
    Tsatsralt-Od B; Takahashi M; Nishizawa T; Inoue J; Ulaankhuu D; Okamoto H
    Arch Virol; 2005 Dec; 150(12):2513-28. PubMed ID: 16012782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of hepatitis C virus among patients with liver disease in the Republic of Yemen.
    Al-Moslih MI; Al-Huraibi MA
    East Mediterr Health J; 2001; 7(4-5):771-8. PubMed ID: 15332778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Retrospective (1970-1984) serological study of delta antigen and antibody. Observations on seroconversion and absence of delta in non-A, non-B hepatitis].
    Stroun J; Peitrequin R; Frei PC
    Schweiz Med Wochenschr; 1987 Feb; 117(9):307-14. PubMed ID: 3105053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High prevalence of hepatitis delta virus infection detectable by enzyme immunoassay among apparently healthy individuals in Mongolia.
    Inoue J; Takahashi M; Nishizawa T; Narantuya L; Sakuma M; Kagawa Y; Shimosegawa T; Okamoto H
    J Med Virol; 2005 Jul; 76(3):333-40. PubMed ID: 15902700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Studies on HDV and HCV infection in plasma donors with positive HBsAg].
    Wang SP; Ding H; Zhao OK
    Zhonghua Yu Fang Yi Xue Za Zhi; 1994 Jul; 28(4):223-4. PubMed ID: 7531135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparison of HBsAg, anti-HCV and anti-HDV positivity in diverse groups].
    Doğanay M; Patiroğlu T; Utaş C; Ozbakir O; Unal A; Utaş S; Aygen B; Yücesoy M
    Mikrobiyol Bul; 1993 Apr; 27(2):107-12. PubMed ID: 7684812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis D infectivity profile among hepatitis B infected hospitalised patients in Calcutta.
    Bhattacharyya S; Dalal BS; Lahiri A
    Indian J Public Health; 1998; 42(4):108-12. PubMed ID: 10389522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of delta antigen/antibody in various HBsAg positive patients in Saudi Arabia.
    Shobokshi OA; Serebour FE
    Prog Clin Biol Res; 1987; 234():471-5. PubMed ID: 2819896
    [No Abstract]   [Full Text] [Related]  

  • 15. [The role of the hepatitis B, C and D viruses in the etiology of chronic hepatopathies in Cluj].
    Neamţu A; Pascu O; Szanto P; Chira O; Neamţu D; State D
    Bacteriol Virusol Parazitol Epidemiol; 1995; 40(2):119-23. PubMed ID: 7549253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seroprevalence of hepatitis D virus and its risk factors in the west of Iran.
    Mohammad Alizadeh AH; Ranjbar M; Tehrani AS; Keramat F; Mamani M; Rezazadeh M; Aini P; Khalilian A; Majlesi A; Hajilooi M
    J Microbiol Immunol Infect; 2010 Dec; 43(6):519-23. PubMed ID: 21195980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of hepatitis D virus infection in hepatitis B surface antigen-positive subjects in Golestan province, northeast Iran.
    Roshandel G; Semnani S; Abdolahi N; Besharat S; Keshtkar AA; Joshaqani H; Moradi A; Kalavi K; Jabbari A; Kabir MJ; Hosseini SA; Sedaqat SM; Danesh A; Roshandel D; Hedayat-Mofidi SM
    J Microbiol Immunol Infect; 2008 Jun; 41(3):227-30. PubMed ID: 18629418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delta hepatitis in Malaysia.
    Sinniah M; Dimitrakakis M; Tan DS
    Southeast Asian J Trop Med Public Health; 1986 Jun; 17(2):229-33. PubMed ID: 3787309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prevalence of serologic markers of hepatitis A, B, C, and D viruses in pregnant women].
    Ortiz-Ibarra FJ; Figueroa-Damián R; Lara-Sánchez J; Arredondo-García JL; Ahued-Ahued JR
    Salud Publica Mex; 1996; 38(5):317-22. PubMed ID: 9092084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis D outbreak among children in a hepatitis B hyper-endemic settlement in Greenland.
    Børresen ML; Olsen OR; Ladefoged K; McMahon BJ; Hjuler T; Panum I; Simonetti J; Jones C; Krarup H; Koch A
    J Viral Hepat; 2010 Mar; 17(3):162-70. PubMed ID: 19780937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.